Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Additionally, GLP-1 agonists should only be used during pregnancy or breastfeeding if the benefits outweigh the risks
This can be related to reduced calorie intake, changes in blood sugar regulation, or general metabolic adjustment
U., Romanova, G
Tirzepatide is a dual GLP-1 and GIP receptor agonist, working on two key metabolic pathways to enhance weight loss, reduce appetite, improve satiety, and support blood sugar regulation
These mechanisms contribute to improved glycaemic control, and clinical trials have demonstrated that Wegovy can reduce HbA1c levels in people with type 2 diabetes
US$ 27.19
US$ 20.91
US$ 24.86
US$ 28.38
US$ 20.62
